These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 21702955)
1. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells. Ishdorj G; Johnston JB; Gibson SB BMC Cancer; 2011 Jun; 11():268. PubMed ID: 21702955 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis. Ishdorj G; Johnston JB; Gibson SB Mol Cancer Ther; 2010 Dec; 9(12):3302-14. PubMed ID: 21159613 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation. Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665 [TBL] [Abstract][Full Text] [Related]
4. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187 [TBL] [Abstract][Full Text] [Related]
5. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Wen-Sheng W Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382 [TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway. Ouafik L; Berenguer-Daize C; Berthois Y Cell Signal; 2009 Apr; 21(4):597-608. PubMed ID: 19166930 [TBL] [Abstract][Full Text] [Related]
7. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. Lee SA; Jung M J Biol Chem; 2007 May; 282(20):15271-83. PubMed ID: 17371872 [TBL] [Abstract][Full Text] [Related]
8. JSI-124 (Cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation. Qi J; Xia G; Huang CR; Wang JX; Zhang J Am J Chin Med; 2015; 43(2):337-47. PubMed ID: 25787299 [TBL] [Abstract][Full Text] [Related]
9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A; Agarwal R; Agarwal C Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755 [TBL] [Abstract][Full Text] [Related]
10. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells. Poindessous-Jazat V; Augery-Bourget Y; Robert-Lézénès J Leukemia; 2002 Feb; 16(2):233-43. PubMed ID: 11840290 [TBL] [Abstract][Full Text] [Related]
11. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. Hsu YL; Kuo PL; Lin LT; Lin CC J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS Blood; 1998 Oct; 92(7):2450-60. PubMed ID: 9746785 [TBL] [Abstract][Full Text] [Related]
13. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Chuang SM; Wang IC; Yang JL Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022 [TBL] [Abstract][Full Text] [Related]
14. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R; Iñiguez MA; Fresno M Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320 [TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Ishikawa Y; Kitamura M Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660 [TBL] [Abstract][Full Text] [Related]
18. Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells. McFarland BC; Gray GK; Nozell SE; Hong SW; Benveniste EN Mol Cancer Res; 2013 May; 11(5):494-505. PubMed ID: 23386688 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling. Yang Y; Ikezoe T; Saito T; Kobayashi M; Koeffler HP; Taguchi H Cancer Sci; 2004 Feb; 95(2):176-80. PubMed ID: 14965369 [TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]